JTCC Immune Cell Therapy Innovations, Interventions and Impact

Add to Calendar JTCC Immune Cell Therapy Innovations, Interventions and Impact 10/9/2026 8:00:00 AM 10/9/2026 3:45:00 PM America/New_York For More Details: https://hmh.cloud-cme.com/course/courseoverview?EID=36853 Description: Join healthcare professionals, researchers and industry leaders for an insightful conference exploring the latest innovations in immune cell therapy and their growing impact on patient care. This comprehensive program will highlight the evolution of CAR-T therapy, advances in immune cell engineering, and emerging applications across oncology and autoimmune diseases. John Theurer Cancer Center, 92 2nd St, Hackensack, NJ 07601 false MM/DD/YYYY


Date & Location
Friday, October 9, 2026, 8:00 AM - 3:45 PM, John Theurer Cancer Center, 92 2nd St, Hackensack, NJ 07601, Hackensack, NJ

Target Audience
Specialties - General, Hematology / Liquid, Oncology
Professions - Allied Health Professional, APN, Non-Physician, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician - Fellow, Physician - Resident, Physician Assistant

Credits
AMA PRA Category 1 Credits™ (4.25 hours), Non-Physician Attendance (4.25 hours)

Overview
Join healthcare professionals, researchers and industry leaders for an insightful conference exploring the latest innovations in immune cell therapy and their growing impact on patient care. This comprehensive program will highlight the evolution of CAR-T therapy, advances in immune cell engineering, and emerging applications across oncology and autoimmune diseases.

Objectives
At the conclusion of this activity, learners should be able to:

  1. Assess the evolving landscape and clinical strategies of immune cell therapy across hematologic malignancies, solid tumors, and autoimmune diseases.
  2. Identify current and emerging immune cell therapy approaches for the treatment of hematologic malignancies, including recent advances, indications and clinical outcomes.
  3. Evaluate the role of immune cell therapies in the management of solid tumors, hematologic malignancies, and autoimmune conditions, with an emphasis on the sequencing of therapies.

Accreditation
Hackensack Meridian Health Network is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians.

Additional Information

Cancellation Policy

HMH reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees, if applicable, will be fully refunded.

Accessibility Statement
 
If you have needs that require special accommodation, including dietary allergies, please contact the Office of Continuing Medical Education.



Keywords: LIVEAMANonPhys